Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AmerisourceBergen Corporation    ABC

AMERISOURCEBERGEN CORPORATION

(ABC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/17/2020 11/18/2020 11/19/2020 11/20/2020 11/23/2020 Date
104.89(c) 103.44(c) 101.9(c) 100.46(c) 100.48(c) Last
2 333 132 898 406 1 481 148 949 240 1 474 349 Volume
-3.78% -1.38% -1.49% -1.41% +0.02% Change
More quotes
Financials (USD)
Sales 2021 201 B - -
Net income 2021 1 582 M - -
Net cash position 2021 1 058 M - -
P/E ratio 2021 13,0x
Yield 2021 1,74%
Sales 2022 211 B - -
Net income 2022 1 689 M - -
Net cash position 2022 1 911 M - -
P/E ratio 2022 12,0x
Yield 2022 1,79%
Capitalization 20 523 M 20 523 M -
EV / Sales 2021 0,10x
EV / Sales 2022 0,09x
Nbr of Employees 21 500
Free-Float 51,0%
More Financials
Company
AmerisourceBergen Corporation specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services,... 
More about the company
Notations Surperformance© of AmerisourceBergen Corporation
Trading Rating : Investor Rating :
More Ratings
All news about AMERISOURCEBERGEN CORPORATION
11/19AMERISOURCEBERGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
11/17Amazon launches online pharmacy in new contest with drug retail
RE
11/13AMERISOURCEBERGEN CORPORATION : Ex-dividend day for
FA
11/09Eli Lilly's Covid-19 Antibody Drug Gets FDA Green Light
DJ
11/05AMERISOURCEBERGEN : Fiscal 4Q Earnings Snapshot
AQ
11/05AMERISOURCEBERGEN CORP : Results of Operations and Financial Condition, Regulati..
AQ
11/05AMERISOURCEBERGEN : Reports Fiscal 2020 Fourth Quarter and Year End Results
BU
10/28Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update
DJ
10/28GILEAD SCIENCES : Quarterly Revenue Rises on Remdesivir Sales
DJ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case
DJ
10/22Walmart Files Pre-emptive Lawsuit Against Federal Government in Opioid Case -..
DJ
10/19AMERISOURCEBERGEN CORP : Entry into a Material Definitive Agreement, Creation of..
AQ
10/18Tax Increase for Corporations Looks More Likely as Election Nears
DJ
10/06AMERISOURCEBERGEN : Announces Date and Time for Fourth Quarter Fiscal 2020 Earni..
BU
10/05AMERISOURCEBERGEN : ION & IPN Solutions Collaborate with Annexus Health to Offer..
PU
More news
News in other languages on AMERISOURCEBERGEN CORPORATION
08/18WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
07/31AMERISOURCEBERGEN CORPORATION : publication des résultats trimestriels
07/31AMERISOURCEBERGEN CORPORATION : Veröffentlichung des Quartalsergebnisses
05/04AMERISOURCEBERGEN CORPORATION : publication des résultats semestriels
05/04AMERISOURCEBERGEN CORPORATION : Veröffentlichung des Halbjahresergebnisses
More news
Analyst Recommendations on AMERISOURCEBERGEN CORPORATION
More recommendations
Stock Trading Strategies
AMERISOURCEBERGEN CORPORATION - 05/11
The stock forcefully approaches new pivot levels
BUY
More Stock Trading Analysis
Chart AMERISOURCEBERGEN CORPORATION
Duration : Period :
AmerisourceBergen Corporation Technical Analysis Chart | ABC | US03073E1055 | MarketScreener
Technical analysis trends AMERISOURCEBERGEN CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 115,94 $
Last Close Price 100,48 $
Spread / Highest target 32,4%
Spread / Average Target 15,4%
Spread / Lowest Target -8,44%
EPS Revisions
Managers
NameTitle
Steven H. Collis Chairman, President & Chief Executive Officer
James Francis Cleary Chief Financial Officer & Executive Vice President
Dale B. Danilewitz Chief Information Officer & Executive VP
Henry Wadsworth McGee Independent Director
Jane Ellen Henney Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMERISOURCEBERGEN CORPORATION18.16%20 523
ABBOTT LABORATORIES25.80%193 666
MEDTRONIC PLC-2.19%149 189
BECTON, DICKINSON AND COMPANY-15.99%66 229
HOYA CORPORATION20.05%44 928
BAXTER INTERNATIONAL INC.-9.39%38 705